Your browser doesn't support javascript.
loading
Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile.
Lillicrap, D; Schiviz, A; Apostol, C; Wojciechowski, P; Horling, F; Lai, C K; Piskernik, C; Hoellriegl, W; Lollar, P.
Affiliation
  • Lillicrap D; Queen's University Kingston, Kingston, ON, Canada.
  • Schiviz A; Baxalta Innovations GmbH, Vienna, Austria.
  • Apostol C; Baxalta Innovations GmbH, Vienna, Austria.
  • Wojciechowski P; Baxalta US Inc., Milford, MA, USA.
  • Horling F; Baxalta Innovations GmbH, Vienna, Austria.
  • Lai CK; Baxalta US Inc., Milford, MA, USA.
  • Piskernik C; Baxalta Innovations GmbH, Vienna, Austria.
  • Hoellriegl W; Baxalta Innovations GmbH, Vienna, Austria.
  • Lollar P; Emory University School of Medicine, Atlanta, GA, USA.
Haemophilia ; 22(2): 308-317, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26278557
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido